ADBiotech Statistics

Total Valuation

ADBiotech has a market cap or net worth of KRW 13.89 billion. The enterprise value is 23.87 billion.

Market Cap	13.89B
Enterprise Value	23.87B

Important Dates

The last earnings date was Friday, March 14, 2025.

Earnings Date	Mar 14, 2025
Ex-Dividend Date	n/a

Share Statistics

ADBiotech has 9.14 million shares outstanding. The number of shares has decreased by -0.09% in one year.

Current Share Class	n/a
Shares Outstanding	9.14M
Shares Change (YoY)	-0.09%
Shares Change (QoQ)	-0.01%
Owned by Insiders (%)	43.28%
Owned by Institutions (%)	5.33%
Float	5.18M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.25
PB Ratio	2.87
P/TBV Ratio	4.30
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.00
EV / Sales	2.14
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.57

Financial Position

The company has a current ratio of 0.62, with a Debt / Equity ratio of 2.46.

Current Ratio	0.62
Quick Ratio	0.35
Debt / Equity	2.46
Debt / EBITDA	n/a
Debt / FCF	-2.74
Interest Coverage	-6.04

Financial Efficiency

Return on equity (ROE) is -103.66% and return on invested capital (ROIC) is -12.06%.

Return on Equity (ROE)	-103.66%
Return on Assets (ROA)	-10.06%
Return on Invested Capital (ROIC)	-12.06%
Return on Capital Employed (ROCE)	-43.01%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	59
Asset Turnover	0.44
Inventory Turnover	3.07

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -52.47% in the last 52 weeks. The beta is 0.88, so ADBiotech's price volatility has been lower than the market average.

Beta (5Y)	0.88
52-Week Price Change	-52.47%
50-Day Moving Average	1,904.10
200-Day Moving Average	2,764.08
Relative Strength Index (RSI)	32.44
Average Volume (20 Days)	117,677

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ADBiotech had revenue of KRW 11.14 billion and -7.95 billion in losses. Loss per share was -870.00.

Revenue	11.14B
Gross Profit	4.01B
Operating Income	-4.12B
Pretax Income	-9.01B
Net Income	-7.95B
EBITDA	-3.09B
EBIT	-4.12B
Loss Per Share	-870.00

Full Income Statement

Balance Sheet

The company has 1.68 billion in cash and 11.72 billion in debt, giving a net cash position of -10.04 billion or -1,098.73 per share.

Cash & Cash Equivalents	1.68B
Total Debt	11.72B
Net Cash	-10.04B
Net Cash Per Share	-1,098.73
Equity (Book Value)	4.77B
Book Value Per Share	529.16
Working Capital	-5.11B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -4.09 billion and capital expenditures -193.38 million, giving a free cash flow of -4.29 billion.

Operating Cash Flow	-4.09B
Capital Expenditures	-193.38M
Free Cash Flow	-4.29B
FCF Per Share	-468.81

Full Cash Flow Statement

Margins

Gross margin is 35.98%, with operating and profit margins of -36.97% and -71.41%.

Gross Margin	35.98%
Operating Margin	-36.97%
Pretax Margin	-80.93%
Profit Margin	-71.41%
EBITDA Margin	-27.77%
EBIT Margin	-36.97%
FCF Margin	n/a

Dividends & Yields

ADBiotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.09%
Shareholder Yield	0.09%
Earnings Yield	-57.24%
FCF Yield	-30.84%

Stock Splits

The last stock split was on May 26, 2021. It was a forward split with a ratio of 3.

Last Split Date	May 26, 2021
Split Type	Forward
Split Ratio	3

Scores

ADBiotech has an Altman Z-Score of -0.92. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.92
Piotroski F-Score	n/a